Analyst Recommendations

Piper Sandler analyst issues NEUTRAL recommendation for BP on February 11, 2026 11:42AM ET. The previous analyst recommendation was Neutral.BP was trading at $36.97 at issue of the...

February 11, 2026   BP 1.18%

Bradesco analyst issues OUTPERFORM recommendation for KOF on February 11, 2026 09:46AM ET. KOF was trading at $112.45 at issue of the analyst recommendation.The overall analyst consensus :...

February 11, 2026   KOF -0.86%

Goldman Sachs analyst issues BUY recommendation for KC on February 10, 2026 09:22PM ET. The previous analyst recommendation was Neutral.KC was trading at $13.12 at issue of the...

February 10, 2026   KC 1.89%

Citigroup analyst issues NEUTRAL recommendation for BHP on February 10, 2026 06:23PM ET. The previous analyst recommendation was Neutral.BHP was trading at $72.34 at issue of the analyst...

February 10, 2026   BHP -0.54%

Barclays analyst issues OVERWEIGHT recommendation for OMAB on February 10, 2026 10:45AM ET. The previous analyst recommendation was Overweight.OMAB was trading at $127.6 at issue of the analyst...

February 10, 2026   OMAB -1.04%

Barclays analyst issues OVERWEIGHT recommendation for VLRS on February 10, 2026 10:45AM ET. The previous analyst recommendation was Overweight.VLRS was trading at $10.47 at issue of the analyst...

February 10, 2026   VLRS -0.52%

Citigroup analyst issues NEUTRAL recommendation for GSK on February 9, 2026 05:48PM ET. The previous analyst recommendation was Neutral.GSK was trading at $58.765 at issue of the analyst...

February 9, 2026   GSK -0.26%

Scotiabank analyst issues SECTOR PERFORM recommendation for VALE on February 9, 2026 03:38PM ET. The previous analyst recommendation was Sector Perform.VALE was trading at $16.485 at issue of...

February 9, 2026   VALE 1.86%

Cowen & Co. analyst issues HOLD recommendation for GSK on February 9, 2026 12:57PM ET. The previous analyst recommendation was Hold.GSK was trading at $60.23 at issue of...

February 9, 2026   GSK -0.26%

Goldman Sachs analyst issues BUY recommendation for TEVA on February 9, 2026 12:37PM ET. The previous analyst recommendation was Buy.TEVA was trading at $34.69 at issue of the...

February 9, 2026   TEVA -0.45%